Oxaydo is owned by Zyla.
Oxaydo contains Oxycodone Hydrochloride.
Oxaydo has a total of 6 drug patents out of which 0 drug patents have expired.
Oxaydo was authorised for market use on 17 June, 2011.
Oxaydo is available in tablet;oral dosage forms.
The generics of Oxaydo are possible to be released after 16 March, 2025.
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7981439 | ZYLA | Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
Nov, 2023
(5 months from now) | |
US7510726 | ZYLA | Methods and compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(5 months from now) | |
US8409616 | ZYLA | Extended release opioid abuse deterrent compositions and methods of making same |
Nov, 2023
(5 months from now) | |
US8637540 | ZYLA | Compositions for deterring abuse of opioid containing dosage forms |
Nov, 2023
(5 months from now) | |
US9492443 | ZYLA | Abuse deterrent compositions and methods of making same |
May, 2024
(11 months from now) | |
US7201920 | ZYLA | Methods and compositions for deterring abuse of opioid containing dosage forms |
Mar, 2025
(1 year, 9 months from now) |
Drugs and Companies using OXYCODONE HYDROCHLORIDE ingredient
Market Authorisation Date: 17 June, 2011
Treatment: NA
Dosage: TABLET;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic